4.6 Article

Blocking eukaryotic initiation factor 4F complex formation does not inhibit the mTORC1-dependent activation of protein synthesis in cardiomyocytes

Related references

Note: Only part of the references are listed.
Article Cardiac & Cardiovascular Systems

Rheb activates protein synthesis and growth in adult rat ventricular cardiomyocytes

Yanni Wang et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2008)

Article Biochemistry & Molecular Biology

PRAS40 regulates mTORC1 kinase activity by functioning as a direct inhibitor of substrate binding

Lifu Wang et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

Review Biochemistry & Molecular Biology

Signalling to translation: how signal transduction pathways control the protein synthetic machinery

Christopher G. Proud

BIOCHEMICAL JOURNAL (2007)

Article Medicine, Research & Experimental

Elevated sensitivity to diet-induced obesity and insulin resistance in mice lacking 4E-BP1 and 4E-BP2

Olivier Le Bacquer et al.

JOURNAL OF CLINICAL INVESTIGATION (2007)

Article Biochemistry & Molecular Biology

Specific isoforms of translation initiation factor 4GI show differences in translational activity

Mark J. Coldwell et al.

MOLECULAR AND CELLULAR BIOLOGY (2006)

Review Physiology

The mTOR pathway in the control of protein synthesis

Xuemin Wang et al.

PHYSIOLOGY (2006)

Review Biochemistry & Molecular Biology

mTOR and cancer therapy

J. B. Easton et al.

ONCOGENE (2006)

Article Peripheral Vascular Disease

Inhibition of mTOR reduces chronic pressure-overload cardiac hypertrophy and fibrosis

Xiao-Ming Gao et al.

JOURNAL OF HYPERTENSION (2006)

Review Biochemistry & Molecular Biology

TOR signaling in growth and metabolism

S Wullschleger et al.

Review Biochemistry & Molecular Biology

TOR signaling in growth and metabolism

Stephan Wullschleger et al.

Review Biochemistry & Molecular Biology

Ribosomal protein S6 phosphorylation: from protein synthesis to cell size

Igor Ruvinsky et al.

TRENDS IN BIOCHEMICAL SCIENCES (2006)

Article Biochemistry & Molecular Biology

Attenuation of cardiac hypertrophy by inhibiting both mTOR and NFκB activation in vivo

TZ Ha et al.

FREE RADICAL BIOLOGY AND MEDICINE (2005)

Review Pharmacology & Pharmacy

Cardiac hypertrophy: A matter of translation

RD Hannan et al.

CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2003)

Article Biochemistry & Molecular Biology

TOS motif-mediated raptor binding regulates 4E-BP1 multisite phosphorylation and function

SS Schaim et al.

CURRENT BIOLOGY (2003)

Article Cardiac & Cardiovascular Systems

Rapamycin attenuates load-induced cardiac hypertrophy in mice

T Shioi et al.

CIRCULATION (2003)

Review Medicine, General & Internal

Drug-eluting stents in vascular intervention

R Fattori et al.

LANCET (2003)

Review Physiology

Cardiac hypertrophy: The good, the bad and the ugly

N Frey et al.

ANNUAL REVIEW OF PHYSIOLOGY (2003)

Article Biochemistry & Molecular Biology

Adipose tissue reduction in mice lacking the translational inhibitor 4E-BP1

K Tsukiyama-Kohara et al.

NATURE MEDICINE (2001)

Article Multidisciplinary Sciences

Activation of NF-κB is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes

NH Purcell et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)

Article Biochemistry & Molecular Biology

Rapid induction of apoptosis mediated by peptides that bind initiation factor eIF4E

TP Herbert et al.

CURRENT BIOLOGY (2000)

Article Cardiac & Cardiovascular Systems

Activation of mRNA translation in rat cardiac myocytes by insulin involves multiple rapamycin-sensitive steps

LJ Wang et al.

AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2000)